Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
This study is enrolling participants by invitation only.
Sponsor:
Johannes Gutenberg University Mainz
Information provided by:
Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT00792649
First received: November 17, 2008
Last updated: NA
Last verified: February 2008
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Colonoscopy is the accepted gold standard for screening of colorectal cancer. However, small and flat neoplastic lesions might be overlooked with standard video endoscopes. The new available EPKi system (Pentax, Japan) enables with HD+ imaging resolution above HDTV standard. Aim of the study was to test the efficacy of HD+ colonoscopy alone and in conjunction with I-Scan (newly developed post processing digital filter)in comparison to standard videoendoscopy
| Condition |
|---|
|
Polyps Neoplasia |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
Resource links provided by NLM:
Further study details as provided by Johannes Gutenberg University Mainz:
| Estimated Enrollment: | 200 |
| Study Start Date: | February 2008 |
| Groups/Cohorts |
|---|
|
1
screening colonoscopy with HD+ endoscopes
|
|
2
screening colonoscopy with standardvideoendoscopes
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Consecutive patients scheduled for screening colonoscopy were examined using HD+ colonosccopes and standardendoscopes.
Criteria
Inclusion Criteria:
- Consecutive patients scheduled for screening colonoscopy
Exclusion Criteria:
- Inflammatory bowel disease
- Cancer
- Pregnancy
- Inability to obtain informed consent
- Prothrombin time < 50% of control
- Partial thromboplastin time > 50 seconds
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Hoffman Arthur |
| ClinicalTrials.gov Identifier: | NCT00792649 History of Changes |
| Other Study ID Numbers: | 837.386.07 |
| Study First Received: | November 17, 2008 |
| Last Updated: | November 17, 2008 |
| Health Authority: | Germany: ethical committee of Rheinland-Pfalz, Germany |
Additional relevant MeSH terms:
|
Neoplasms |
ClinicalTrials.gov processed this record on May 23, 2013